Liver transplantation and recurrent hepatocellular carcinoma: Predictive value of nodule size in a retrospective and explant study

Transplantation

Volumn 81, Issue 11, 2006, Pages 1532-1541

  Grasso, Alessandro ^a,b   Stigliano, Rosa ^a,b   Morisco, Filomena ^a,b   Martines, Hugo ^c   Quaglia, Alberto ^b,d   Dhillon, Amar P ^b,d   Patch, David ^a,b   Davidson, Brian R ^a,b   Rolles, Keith ^a,b   Burroughs, Andrew K ^a,b  

^a Liver Transplantation and Hepatobiliary Unit   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c San Paolo Hospital   (Italy)

^d Department of Histopathology ^*  (United Kingdom)

Author keywords

Explant; Largest nodules; Milan criteria; Selection

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EVALUATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY;

ADULT; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; INCIDENTAL FINDINGS; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; WAITING LISTS;

EID: 33745175918     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000209641.88912.15     Document Type: Article

References (49)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907.
2. Burroughs A, Hochhauser D, Meyer T. Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of therapeutic spectrum. Lancet Oncol 2004; 5: 409.
3. Yoo HY, Patt CH, Geschwind JF, Thuluvath PJ. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significant with time. J Clin Oncol 2003; 21: 4329.
4. Iwatsuki S, Gordon RD, Shaw BW, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 1985; 202: 401.
5. O'Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Result in 93 consecutive patients. Ann Surg 1988; 207: 373.
6. Ringe B, Wittekind C, Bechstein WO, Pichlmayr L. Role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 1989; 209: 88.
7. Iwatsuki S, Starzl TE, Sheahan DG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991; 214: 221.
8. Bismuth H, Cliché L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 218: 145.
9. Selby R, Zakiyah K, Carr B, Tzakis A, Madariaga JR, Iwatsuki S. Transplantation for hepatocellular carcinoma. World J Surg 1995; 19: 53.
10. Penn I. Hepatic transplantation for primary and metastatic cancer of the liver. Surgery 1991; 110: 726.
11. Pichlmayr R, Weimann A, Oldhafer KJ, et al. Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg 1995; 19: 807.
12. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 1996; 334: 693.
13. Figueras J, Jaurrieta E, Valls C, et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997; 25: 1485.
14. Llovet JM, Bruix J, Fuster J, et al. Liver transplantation for treatment of small hepatocellular carcinoma: the TNM classification does not have prognostic power. Hepatology 1998; 27: 1572.
15. Regalia E, Fassati LR, Valente U, et al. Pattern and management of recurrent hepatocellular carcinoma after liver transplantation. J Hepatobiliary Pancreat Surg 1998; 5: 293.
16. Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999; 19: 311.
17. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080.
18. Tamura S, Kato T, Berho M, et al. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg 2001; 136: 25.
19. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394.
20. Herrero JI, Sangro B, Quiroga J, et al. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl 2001; 7: 631.
21. Figueras J, Ibanez L, Ramos E, et al. Selection criteria for liver transplantation in end-stage hepatocellular carcinoma with cirrhosis: result for a multicenter study. Liver Transpl 2001; 7: 877.
22. Moya A, Berenguer M, Aguilera V, et al. Hepatocellular carcinoma: can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C. Liver Transpl 2002; 8: 1020.
23. De Carlis L, Giacomoni A, Lauterio A, et al. Liver transplantation for hepatocellular cancer: should the current indication criteria be changed? Transpl Int 2003; 16: 115.
24. Shetty K, Timmins K, Brensinger C, et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 2004; 10: 911.
25. Margarit C, Charco R, Hidalgo E, Allende E, Castells L, Bilbao I. Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg 2002; 26: 257.
26. Klintmalm GB. Liver transplantation for hepatocellular carcinoma. A registry report of the impact of tumor characteristics on outcome. Ann Surg 1998; 4: 479.
27. Otto G, Keuschen U, Hofmann WJ, Krumm G, Hinz H, Herfarth C. Survival and recurrence after transplantation versus liver resection for hepatocellular carcinoma. A retrospective analysis. Ann Surg 1998; 3: 424.
28. Marsh JW, Dvorchik I, Subotin M, et al. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology 1997; 26: 444.
29. Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 2000; 19: 389.
30. Molmenti EP, Klintmalm GB. Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry. Liver Transpl 2002; 8: 736.
31. Pugh RN, Murray-Lion IM, Dawson JL, Pietroni MC, Williams R. Transection of the esophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646.
32. Edmondson H, Steiner P. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 1: 462.
33. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22: 983.
34. American Liver Tumor Study Group. A randomised prospective multi-institutional trial of orthotopic liver transplantation or partial hepatic resection with or without adjuvant chemotherapy for hepatocellular carcinoma. Investigator Booklet and Protocol. 1998.
35. International Union Against Cancer (UICC). TNM classification of malignant tumours. In: Sobin, LH, Wittekind CH, eds. 5th ed. New York, Wiley-Liss 1997, p 74.
36. Ravaioli M, Ercolani G, Cescon M, et al. Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. Liver Transpl 2004; 10: 195.
37. Roayaie S, Schwartz JD, Sung MW, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 2004; 10: 534.
38. Llovet JM, Fuster J, Bruix J, et al for the Barcelona Clinic Liver Cancer (BCLC) Group. Intention-to-treat analysis of survival treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 39:1434.
39. Vivarelli M, Bellusci R, Cucchetti A, et al. Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patients selection or lower immunosuppression? Transplantation 2002; 74: 1746.
40. Paulik TM, Delman KA, Vauthey JN, et al. Tumour size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005; 11: 1086.
41. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Robert JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002; 8: 765.
42. Marsh JW, Dvorchik I. Liver organ allocation for hepatocellular carcinoma: are we sure? Liver Transpl 2003; 9: 693.
43. Todo S, Furukawa H, et al. Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004; 240:451.
44. Esnaola NF, Lauwers GY, Mirza NQ, et al. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 2002; 6: 224.
45. Guerra A, Crespo J, Cayon A, Gonzales F, Silvan M, Pons-Romero F. Hematogenuous dissemination of malignant hepatocytes during liver transplantation. J Hepatol 2003; 38(suppl. 2): 91.
46. Witzigmann H, Geissler F, Benedix F, et al. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. Surgery 2002; 131: 34.
47. Capurro M, Wanless IR, Sherman M, et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003; 125: 89.
48. Chao Y, Li CP, Chau GY, et al. Prognostic significance of vascular endothelial growth factor, basic fibroblast and angiogenin in patients with resectable hepatocellular carcinoma after surgery. Ann Surg Oncol 2003; 10: 355.
49. Pan HW, Ou YH, Peng SY, et al. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer 2003; 98: 119.